Literature DB >> 10232580

Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.

G Deng1, A Chen, J Hong, H S Chae, Y S Kim.   

Abstract

Microsatellite instability (MSI) has been described in tumors from patients with hereditary nonpolyposis colorectal cancer, sporadic colorectal cancer, and other types of cancers. MSI is caused by the dysfunction of mismatch repairs genes. Loss of expression and mutation in one of the major mismatch repair genes, hMLH1, and the methylation of CpG sites in its promoter occur frequently in primary tumors and cell lines of colorectal cancer with MSI. To understand the mechanisms involved in the silencing of hMLH1 expression by methylation, we examined the methylation status of all CpG sites in the hMLH1 promoter in 24 colorectal cancer cell lines by the NaHSO3-sequencing method. We identified a small proximal region (-248 to -178, relative to the transcription start site) in the promoter in which the methylation status invariably correlates with the lack of hMLH1 expression. This correlation was further supported by the observation that cell lines that showed methylation-suppressed hMLH1 expression can be induced to reexpress hMLH1 by a methyl transferase inhibitor, 5-aza-2'-deoxycytidine, and the small region that we identified exhibited significant demethylation in all cell lines examined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232580

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  108 in total

1.  MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Authors:  Mireia Gausachs; Pilar Mur; Julieta Corral; Marta Pineda; Sara González; Llúcia Benito; Mireia Menéndez; Josep Alfons Espinàs; Joan Brunet; María Dolores Iniesta; Stephen B Gruber; Conxi Lázaro; Ignacio Blanco; Gabriel Capellá
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study.

Authors:  Lars Henrik Jensen; Anders Aamann Rasmussen; Lene Byriel; Hidekazu Kuramochi; Dorthe Gylling Crüger; Jan Lindebjerg; Peter V Danenberg; Anders Jakobsen; Kathleen Danenberg
Journal:  Cell Oncol (Dordr)       Date:  2013-09-12       Impact factor: 6.730

3.  HOXA5 regulates hMLH1 expression in breast cancer cells.

Authors:  Sai Duriseti; Paul T Winnard; Yelena Mironchik; Farhad Vesuna; Ana Raman; Venu Raman
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

4.  Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Hongfen Lu; Yingqiang Shi; Peng Lian; Junjie Peng; Xiang Du; Xiaoyan Zhou; Zuqing Guan; Daren Shi; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

5.  Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography.

Authors:  Dajun Deng; Guoren Deng; Michael F Smith; Jing Zhou; Huijun Xin; Steven M Powell; Youyong Lu
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

6.  Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.

Authors:  Yu-Wei Cheng; Carrie Shawber; Dan Notterman; Philip Paty; Francis Barany
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

7.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Mark Clendenning; Kaisa Sotamaa; Thomas Prior; Judith A Westman; Jenny Panescu; Dan Fix; Janet Lockman; Jennifer LaJeunesse; Ilene Comeras; Albert de la Chapelle
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

Review 8.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.

Authors:  Larissa A Meyer; Russell R Broaddus; Karen H Lu
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

9.  Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission.

Authors:  Déborah Martínez-Baños; Beatríz Sánchez-Hernández; Guadalupe Jiménez; Georgina Barrera-Lumbreras; Olga Barrales-Benítez
Journal:  Exp Ther Med       Date:  2017-03-28       Impact factor: 2.447

10.  Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells.

Authors:  Aye Aye Thant; Yanyuan Wu; Jane Lee; Dhruva Kumar Mishra; Heather Garcia; H Phillip Koeffler; Jaydutt V Vadgama
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.